InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: loanranger post# 230503

Tuesday, 06/12/2018 8:25:00 AM

Tuesday, June 12, 2018 8:25:00 AM

Post# of 403074
Well, if you take a really generous look at B maybe you can say that next phase in ABSSSI would be phase 3 because of large past ABSSSI trials. Never mind that the next trial will probably be p1 or p2 in anything but ABSSSI.

You have encountered a prime example of pharma's eternally optimistic forward looking clinical parlance: If a drug clears phase X trial in indication Y it is instantly promoted to be known as phase X+1 drug (no mention of indication Y unless really, really necessary like when presenting in front of serious investors). Looks so much better in general purpose press releases when you omit that "in Y indication".

Not really a joke. I am more than half serious.

"There's no sense in being precise when you don't even know what you're talking about." John v. Neumann

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News